BTIG Downgrades Ginkgo Bioworks Holdings to Sell
Portfolio Pulse from Benzinga Newsdesk
BTIG analyst Mark Massaro has downgraded Ginkgo Bioworks Holdings (NYSE:DNA) from Neutral to Sell.
May 15, 2024 | 5:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
BTIG analyst Mark Massaro has downgraded Ginkgo Bioworks Holdings from Neutral to Sell, indicating a negative outlook on the stock.
The downgrade from Neutral to Sell by a reputable analyst suggests a negative sentiment towards Ginkgo Bioworks Holdings, which is likely to result in a short-term decline in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100